OLA1

Obg like ATPase 1

Basic information

Region (hg38): 2:174072447-174248599

Previous symbols: [ "GTPBP9" ]

Links

ENSG00000138430NCBI:29789OMIM:611175HGNC:28833Uniprot:Q9NTK5AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OLA1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OLA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
16
clinvar
16
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 16 0 0

Variants in OLA1

This is a list of pathogenic ClinVar variants found in the OLA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-174075472-A-G not specified Uncertain significance (Sep 07, 2022)2218989
2-174078985-A-T not specified Uncertain significance (Apr 12, 2023)2522709
2-174081168-C-T not specified Uncertain significance (Apr 12, 2024)2351267
2-174081219-A-T not specified Uncertain significance (Mar 30, 2024)3302249
2-174081927-T-C not specified Uncertain significance (Aug 02, 2022)2304634
2-174081939-G-T not specified Uncertain significance (Mar 30, 2024)3302254
2-174081941-T-G not specified Uncertain significance (Mar 20, 2023)2526826
2-174081957-C-T not specified Uncertain significance (Mar 30, 2024)3302253
2-174081973-A-T not specified Uncertain significance (Mar 30, 2024)3302252
2-174081974-T-A not specified Uncertain significance (Mar 30, 2024)3302251
2-174082006-A-C Malignant tumor of prostate Uncertain significance (-)161492
2-174082017-A-G not specified Uncertain significance (Feb 06, 2023)3204181
2-174082027-G-A not specified Uncertain significance (Jun 30, 2022)3204180
2-174082033-A-G not specified Uncertain significance (Mar 30, 2024)3302250
2-174123617-T-C not specified Uncertain significance (Jun 21, 2023)2604593
2-174123669-T-G not specified Uncertain significance (Jan 30, 2024)3204179
2-174141892-C-T not specified Uncertain significance (Oct 26, 2022)2217938
2-174141940-A-G not specified Uncertain significance (Oct 12, 2022)2223393
2-174223040-A-T not specified Uncertain significance (Dec 15, 2023)3204178
2-174223105-G-A not specified Uncertain significance (Aug 02, 2022)2304814
2-174223107-G-A not specified Uncertain significance (Jun 06, 2023)2557128
2-174229354-G-A not specified Uncertain significance (Jul 21, 2021)2239188
2-174246742-A-G not specified Uncertain significance (Jun 17, 2024)3302248
2-174246778-G-A not specified Uncertain significance (Jul 05, 2022)2366071

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OLA1protein_codingprotein_codingENST00000284719 10176252
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.05810.9411257260131257390.0000517
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.751312010.6520.000009462632
Missense in Polyphen3775.4110.490641041
Synonymous-0.6747467.01.100.00000329698
Loss of Function2.98620.60.2920.00000103268

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006450.0000615
Ashkenazi Jewish0.000.00
East Asian0.00005690.0000544
Finnish0.000.00
European (Non-Finnish)0.00006480.0000615
Middle Eastern0.00005690.0000544
South Asian0.0001410.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Hydrolyzes ATP, and can also hydrolyze GTP with lower efficiency. Has lower affinity for GTP. {ECO:0000255|HAMAP- Rule:MF_03167}.;
Pathway
Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis (Consensus)

Recessive Scores

pRec
0.253

Intolerance Scores

loftool
0.448
rvis_EVS
-0.23
rvis_percentile_EVS
37.11

Haploinsufficiency Scores

pHI
0.529
hipred
Y
hipred_score
0.528
ghis
0.610

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ola1
Phenotype
homeostasis/metabolism phenotype; growth/size/body region phenotype; respiratory system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype;

Gene ontology

Biological process
platelet degranulation;ATP metabolic process
Cellular component
extracellular region;nucleolus;cytoplasm;centrosome;cytosol;membrane;platelet alpha granule lumen;extracellular exosome
Molecular function
protein binding;ATP binding;GTP binding;ATPase activity;ribosome binding;ribosomal large subunit binding;cadherin binding;metal ion binding